NEC orchestrating a brighter world
NEC Laboratories Europe

NEC Laboratories Europe

Technologies for a better tomorrow

Collaborate & Invent.

Fundamental and applied research. Tech discovery. Top-tier scientific publications. Innovative patents.

Research

Artificial Intelligence

Advancing LLMs, generative AI and applying human centricity to create more meaningful collaboration between people and AI.

Learn more

6G Networks

Designing and optimizing networked systems to further society’s digital transformation.

Learn more

Security

Paving the way for a secure Web 3.0 environment with self-sovereign identities, decentralized trust, blockchain security, systems security and applied cryptography.

Learn more

Systems Platforms for AI

Improving data architectures and frameworks. Developing technology for AI and parallel computing that intersects domain-specific programming languages and software engineering.

Learn more

Case Studies

Discover how our research is advancing science and technology.
Technology Overview    |    Jul 04, 2024

Towards Safer Large Language Models

Human-Centric AI LLMs AI Machine Learning Explainable AI Fact checking NLP Information extraction LLM Explainer Fact Checker

Large language models (LLMs) have emerged as a transformative force – but not without significant risk. Understand the scope of LLM’s as we explore their benefits, limitations and safe use – minimizing incorrect output such as hallucinations.

Scientific Brief    |    Apr 12, 2024

Identifying Facts in Text with Fact Extractor

Human-Centric AI Knowledge graphs Qualitative evaluation Multilingual systems Explainable AI Information extraction Annotation platform Datasets

Information is being generated faster than humans can process it. This impedes our ability to acquire knowledge, which is slowing down scientific discovery and the advancement of technology. How can humans absorb information at the pace it is being created?

Technology Overview    |    Mar 28, 2024

Human-Centric AI: A Road Map to Human-AI Collaboration

Human-Centric AI Multilingual systems Datasets Annotation platform Explainable AI Qualitative evaluation Knowledge graphs

AI systems perform tasks that normally would require human intelligence, and can accomplish them faster by rapidly consuming and analysing large amounts of complex data. That’s the theory. In practice, many instances of applied AI fail spectacularly. In some cases, we don’t even notice!

About us

We find new ways to push the boundaries of science, delivering technology that significantly benefits the environment, society and our lives.
Dr. Jürgen Quittek

Our researchers choose their own projects, lead scientific discovery and regularly present their results at top, peer-reviewed scientific conferences. We are committed to open-innovation technology that benefits science and society.

Technology

Learn how our technology is helping to solve society’s greatest challenges.

Pioneering Graph-Based Relational Learning

NEC Laboratories Europe is a world pioneer in advancing and applying graph-based relational learning. Our GraphAI technology discovers and exploits relations between data entities, eliminating the problem of missing data points and linking multimodal data.

Accelerating Vaccine Discovery with Software Optimization

Governments and scientists are in a race against time to identify and control the spread of emerging viruses before they become pandemics. NEC Laboratories Europe is currently working with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop vaccines effective against SARS-CoV-2 variants and other betacoronaviruses.

A New Frontier in Personalized Therapeutic Cancer Vaccines

Neoantigens can be used to develop personalized therapeutic cancer vaccines that teach the patient's immune system to recognize and kill cancer cells. The NEC Neoantigen Prediction Pipeline uses bioinformatics and machine learning to analyze the DNA and RNA of cancer patients to identify neoantigens originating from cancer mutations. NEC Laboratories Europe was a key contributor in developing the prediction pipeline, which enables NEC biotech partners to advance immunotherapy.
Top of this page